SNDX Latest Quarter’s Earnings
Announce Date11/2/2026
EPS Actual (USD)-0.55
Revenue Actual (USD)83.30M
Syndax Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed Syndax Pharmaceuticals Inc earnings data including the latest Syndax Pharmaceuticals Inc earnings report, the upcoming Syndax Pharmaceuticals Inc earnings date, historical data and Syndax Pharmaceuticals Inc earnings call news.
SNDX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
SNDX FY2025 Earnings
EPS (YoY)-3.2911.50%
Revenue (YoY)172.35M627.84%
Syndax Pharmaceuticals Inc (SNDX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/2/2026 | 09/2026 | -0.55/-0.49 | 83.30M/81.85M | -11.86% | 1.77% |
| 8/4/2026 | 06/2026 | -0.55/-0.44 | 72.79M/79.32M | -25.42% | -8.24% |
| 4/30/2026 | 03/2026 | -0.48/-0.58 | 64.86M/70.44M | 16.93% | -7.91% |
| 2/26/2026 | 12/2025 | -0.78/-0.58 | 68.73M/63.97M | -33.99% | 7.44% |
| 11/3/2025 | 09/2025 | -0.70/-0.72 | 45.87M/47.98M | 2.20% | -4.39% |
| 8/4/2025 | 06/2025 | -0.83/-1.02 | 37.96M/26.82M | 18.10% | 41.50% |
| 5/5/2025 | 03/2025 | -0.98/-1.33 | 20.04M/14.43M | 26.01% | 38.86% |
| 3/3/2025 | 12/2024 | -1.09/-0.23 | 7.68M/85.91M | -374.73% | -91.06% |
Syndax Pharmaceuticals Inc Latest Earnings Call Transcripts
Syndax Pharmaceuticals (SNDX) Q3 2026 Earnings Call: Revenue Rises 82% on Revuforj Growth
Syndax Pharmaceuticals Q3 2026 earnings call: revenue rose 82% to $83.3 million as Revuforj grew, while quarter-end cash reached $551 million.